Skip to main content
Book Chapter

Regulatory framework for hemoglobin-based oxygen carrier trials

Springer-Verlag Berlin Heidelberg, (2013), 149-156
DOI: 10.1007/978-3-642-40717-8_9
N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Oxygen therapeutics (OT) consist of hemoglobin-based oxygen carriers (HBOCs) and fluorocarbons. They have been developed to deliver oxygen (O2) to tissues, mainly for treatment of shock due to blood loss. These products are being developed in order to treat blood loss when red blood cells are not available, as may occur on the battlefield or in civilian life when trauma occurs.

Cite

CITATION STYLE

APA

Golding, B. (2013). Regulatory framework for hemoglobin-based oxygen carrier trials. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics (Vol. 9783642407178, pp. 149–156). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free